Stefan Rose-John
12Patents
4h-index
18Co-inventors
53Inventor score
Filing activity: Mar 7, 1997 → Aug 16, 2013
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7112436B1 | Conjugate for modifying interactions between proteins | Chemistry; Metallurgy | 33 | Expired |
| US7534862B2 | PEGylated soluble gp130-dimers useful as a medicament | Chemistry; Metallurgy | 9 | Expired |
| US7629147B2 | PEGylated soluble GP130-dimers useful as a medicament | Chemistry; Metallurgy | 8 | Active |
| US5919763A | IL-6/SIL-6R complex for promotion of liver functions | Human Necessities | 5 | Expired |
| US5935569A | Genetic anticancer vaccine | Human Necessities | 2 | Expired |
| US6280975A | IL-6 mutein and DNA encoding thereto | Human Necessities | 0 | Expired |
| US7897145B2 | Methods for the treatment of renal failure | Human Necessities | 0 | Active |
| US9765129B2 | Treatment of obesity | Chemistry; Metallurgy | 0 | Active |
| US9187542B2 | Ciliary neurotrophic factor variants | Human Necessities | 0 | Active |
| US8206948B2 | Optimized nucleotide sequences encoding sgp130 | Chemistry; Metallurgy | 0 | Active |
| US8372389B2 | Methods for the treatment of radiation or chemotherapy-induced tissue damage | Chemistry; Metallurgy | 0 | Active |
| US8501696B2 | Soluble GP130 muteins with improved binding activity | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.